Bausch Health Compan
Delayed Toronto Stock Exchange - 07/24 11:39:59 pm
29.73CAD
-0.44%
Prev.29.8600
Open29.8100
High30.2200
Low29.6500
Volume433 592
Financials
Sales 2018 8 466 M
EBIT 2018 3 098 M
R. net 2018 -3 712 M
Debt 2018 23 890 M
Rend. 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 3,68x
EV / Sales 2019 3,56x
Capitalization 7 290 M
Company
Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products.It operates through the following segments: The Bausch + Lomb/International, Branded Rx, and U.S....
Sector :
Pharmaceuticals - NEC
Calendar :
No events available
Trading Rating :
Investor Rating :
Latest news
07/12VALEANT PHARMACEUTICALS INTL : Trademark Application for "INTELLIGENT OPTICAL TRACKING" Filed by Valeant Pharmaceuticals
AQ
07/11VALEANT PHARMACEUTICALS INTL : Bausch + Lomb Announces U.S. FDA Filing Acceptance for Loteprednol Etabonate Ophthalmic Gel, 0.38%
AQ
07/09Today's Research Reports on Acerus Pharmaceuticals, IMV, Valeant Pharmaceuticals and BELLUS Health
AC
07/09BAUSCH + LOMB : Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
PR
07/05VALEANT PHARMACEUTICALS INTL : FDA Issues Complete Response Letter For DUOBRII™ Halobetasol Propionate and Tazarotene Lotion
AQ
06/29VALEANT PHARMACEUTICALS INTL : Salix and US WorldMeds Enter into Exclusive Co-Promotion Agreement for Opioid Withdrawal Treatment LUCEMYRA
AQ
06/28VALEANT PHARMACEUTICALS INTL : FDA Issues Complete Response Letter For DUOBRII™ Halobetasol Propionate and Tazarotene Lotion
AQ
06/28Complimentary Technical Snapshots on Valeant Pharmaceuticals International and Three More Healthcare Stocks
AC